相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Levodopa Equivalent Dose Conversion Factors: An Updated Proposal Including Opicapone and Safinamide
Sebastian Schade et al.
MOVEMENT DISORDERS CLINICAL PRACTICE (2020)
Long-term efficacy of opicapone in fluctuating Parkinson's disease patients: a pooled analysis of data from two phase 3 clinical trials and their open-label extensions
J. J. Ferreira et al.
EUROPEAN JOURNAL OF NEUROLOGY (2019)
Bound, free, and total l-dopa measurement in plasma of Parkinson's disease patients
Thomas Mueller et al.
JOURNAL OF NEURAL TRANSMISSION (2019)
Hypomethylation in Parkinson's disease: An epigenetic drug effect?
Thomas Mueller et al.
MOVEMENT DISORDERS (2016)
Catechol-O-Methyltransferase Inhibitors in Parkinson's Disease
Thomas Mueller
DRUGS (2015)
Effect of opicapone and entacapone upon levodopa pharmacokinetics during three daily levodopa administrations
Jose-Francisco Rocha et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Pharmacokinetics, Pharmacodynamics and Tolerability of Opicapone, a Novel Catechol-O-Methyltransferase Inhibitor, in Healthy Subjects
Luis Almeida et al.
CLINICAL PHARMACOKINETICS (2013)
Inhibition of catechol-O-methyltransferase modifies acute homocysteine rise during repeated levodopa application in patients with Parkinson's disease
Thomas Mueller et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2011)
Initiating Levodopa/Carbidopa Therapy With and Without Entacapone in Early Parkinson Disease The STRIDE-PD Study
Fabrizio Stocchi et al.
ANNALS OF NEUROLOGY (2010)
Acute homocysteine rise after repeated levodopa application in patients with Parkinson's disease
Thomas Mueller et al.
PARKINSONISM & RELATED DISORDERS (2010)
Comparison of pharmacokinetic profile of levodopa throughout the day between levodopa/carbidopa/entacapone and levodopa/carbidopa when administered four or five times daily
Mikko Kuoppamaki et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Peripheral COMT inhibition prevents levodopa associated homocysteine increase
Thomas Mueller et al.
JOURNAL OF NEURAL TRANSMISSION (2009)
Homocysteine Levels After Acute Levodopa Intake in Patients with Parkinson's Disease
Thomas Mueller et al.
MOVEMENT DISORDERS (2009)
Double-Blind Trial of Levodopa/Carbidopa/Entacapone Versus Levodopa/Carbidopa in Early Parkinson's Disease
Robert A. Hauser et al.
MOVEMENT DISORDERS (2009)
Pharmacokinetic behaviour of levodopa and 3-O-methyldopa after repeat administration of levodopa/carbidopa with and without entacapone in patients with Parkinson's disease
T. Mueller et al.
JOURNAL OF NEURAL TRANSMISSION (2006)
Inhibition of catechol-O-methyltransferase contributes to more stable levodopa plasma levels
T Müller et al.
MOVEMENT DISORDERS (2006)
Entacapone is beneficial in both fluctuating and non-fluctuating patients with Parkinson's disease: a randomised, placebo controlled, double blind, six month study
DJ Brooks et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2003)
Methylation and acetylation in nervous system development and neurodegenerative disorders
MP Mattson
AGEING RESEARCH REVIEWS (2003)
分享论文
